article thumbnail

STAT+: U.S. judge orders Minnesota to pause its drug pricing transparency law over constitutional issues

STAT

The Minnesota law, which was enacted in 2020 but strengthened this past May, resembles other so-called transparency laws in some other states. It seeks to identify the factors driving prescription drug costs higher and correlate these to certain expenses, revenue, and profits reported by pharmaceutical manufacturers.

article thumbnail

STAT+: FDA efforts to oversee foreign drug manufacturing remain inadequate to ensure safety, analysis finds

STAT

Specifically, there was a 79% drop in inspections of pharmaceutical manufacturing plants in foreign countries and a 35% decline in domestic facilities from 2019 to 2022. For foreign facilities, about 17% of all inspections conducted the past two years yielded citations compared with just 5% in 2020.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Understanding the Regulatory Environment in Japan for Generic Drug Development

Drug Patent Watch

Retrieved from [link] Japan Pharmaceutical Manufacturers Association. Pharmaceutical Regulations in Japan 2020. Retrieved from [link] Pharmaceuticals and Medical Devices Agency. Freyr Solutions. 11 Must-know FAQs about the Drug Approval Process in Japan. Regulatory System on Generic Drugs in Japan.

article thumbnail

Common pharma compliance concerns cited by FDA warning letters

European Pharmaceutical Review

A study of the causes of warning letters issued by the US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) and Center for Devices and Radiological Health (CDRH) between 2010 and 2020 revealed that poor current good manufacturing practice (cGMP) compliance and misbranding were the most common citations.

article thumbnail

Granules India Limited- Walk-In Drive for ITI, Diploma, B.Sc, B.Com Freshers On 14th Dec’ 2022

Pharma Pathway

Company Profile: Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, Indian. Granules manufacturing several off-patent drugs, including Paracetamol, Ibuprofen, Metformin and Guaifenesin, on a large scale for customers in the regulated and rest of the world markets. Job Description.

article thumbnail

NEW: The 2020–21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

Drug Channels

I am pleased to announce our new 2020–21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. Drug Distribution Industry (press release) We’re offering special discounted pricing if you order before October 23, 2020! healthcare system.

article thumbnail

Granules India Limited- Walk-In Drive for Freshers in Quality Control/ Production/ Warehouse On 16th Feb’ 2023

Pharma Pathway

Granules India Limited- Walk-In Drive for Freshers in Quality Control/ Production/ Warehouse On 16th Feb’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceutical manufacturing company based in Hyderabad, Indian. Walk-In Drive for B.Sc / M.Sc/ B.Pharm/ B.Com/ B.A/